Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EBR/OXUR stock hub

EBR/OXUR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EBR/OXURis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

337K

Euronext Brussels

Market data

Price

Recent price action with selectable time range.

EBR/OXUREBR/OXUR

—

Loading chart…

In the news

Latest news · EBR/OXUR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E0

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EBR/OXUR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

EUR

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Belgium
Country code	BE
Employees	11
Employees Change	-9%
Employees Change Percent	-45
Enterprise value	EUR 11.2M
Exchange	Euronext Brussels
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	BE0003846632
Last refreshed	2026-05-10
Market cap	EUR 337,027
Price	EUR 0
Price currency	EUR
Rev Per Employee	181.82x
Sector	Healthcare
Sic	2836
Symbol	ebr/OXUR
Website	https://www.oxurion.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	581.26%
EV Earnings	5.7x
EV/EBIT	12.39x
EV/EBITDA	11.52x
P/B ratio	-0.03x
P/E ratio	0.01x
P/S ratio	168.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	45,050%
EBITDA Margin	45,600%
Gross Profit	EUR -13,000
Net Income	EUR 2M
Net Income Growth Quarters	5%
Net Income Growth Years	2%
Pretax Margin	98,050%
Profit Margin	97,950%
Profit Per Employee	EUR 178,091
Profitable Years	1
ROA	11.82
Roa5y	-53.19
ROCE	-7.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-79.76%
Cagr15y	-69.5%
Cagr1y	-94.87%
Cagr3y	-95.7%
Cagr5y	-95.67%
EPS Growth Quarters	8
EPS Growth Years	3
Revenue Growth	-97.62x
Revenue Growth Years	0x
Revenue Growth3 Y	-80.34x
Revenue Growth5 Y	-67.99x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0
Assets	EUR 5M
Cash	EUR 6,000
Current Assets	EUR 2.9M
Current Liabilities	EUR 16.9M
Debt	EUR 10.8M
Debt EBITDA	EUR 11.18
Equity	EUR -12M
Liabilities	EUR 17M
Long Term Assets	EUR 2.1M
Long Term Liabilities	EUR 124,000
Net Cash	EUR -10.8M
Net Cash By Market Cap	EUR -3,212
Net Debt EBITDA	EUR 11.87
Tangible Book Value	EUR -12M
Tangible Book Value Per Share	EUR -2.43
WACC	0.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.17
Net Working Capital	EUR -3.1M
Quick ratio	0.17
Working Capital	EUR -14M
Working Capital Turnover	EUR -0

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-94.86%
200-day SMA	0.01
3Y total return	-99.99%
50-day SMA	0
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	478,200
All Time High Change	-100%
All Time High Date	2013-01-09
All Time Low	0
All Time Low Change	5.56%
All Time Low Date	2026-05-06
ATR	0
Beta	-0.15
Beta1y	0.04
Beta2y	0.44
Ch YTD	-47.22
High	0
High52	0.08
High52 Date	2025-07-24
High52ch	-95.48%
Low	0
Low52	0
Low52 Date	2026-05-06
Low52ch	5.56%
Ma50ch	-22.45%
Price vs 200-day SMA	-69.35%
RSI	39.05
RSI Monthly	21.58
RSI Weekly	23.45
Sharpe ratio	-1.74x
Sortino ratio	-2.79
Tr YTD	-47.22
Tr15y	-100%
Tr1m	-17.39%
Tr1w	-5%
Tr3m	-45.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 901,000
Operating Income Growth	135.9
Operating margin	45,050

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	76,832,300%
Net Borrowing	1,147,000
Shares Institutions	0.92%
Shares Out	88,691,312

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	367,823.4x
Bv Per Share	-2.43
Ch10y	-100
Ch15y	-100
Ch1m	-17.39
Ch1w	-5
Ch1y	-94.86
Ch3m	-45.71
Ch3y	-99.99
Ch5y	-100
Ch6m	-65.45
Change	0%
Change From Open	0
Close	0
Days Gap	0
Depreciation Amortization	11,000
Dollar Volume	315.8
Earnings Date	2026-04-03
EBIT	EUR 901,000
EBITDA	EUR 912,000
EPS	EUR 0.4
F Score	3
Financing CF	1,199,000
Fiscal Year End	December
Founded	1,991
Income Tax	EUR 2,000
Investing CF	110,000
Is Primary Listing	1
Last Earnings Date	2026-04-03
Last Report Date	2025-06-30
Last Split Date	2024-09-03
Last Split Type	Reverse
Ma150	0.01
Ma150ch	-53.66%
Ma20	0
Ma20ch	-5%
Net CF	-113,000
Open	0
Position In Range	0
Ppne	15,000
Price Date	2026-05-08
Price EBITDA	EUR 0.37
Relative Volume	0.23x
Revenue	2,000x
SBC By Revenue	1,200x
Share Based Comp	24,000
Tax By Revenue	100x
Tax Rate	0.1%
Tr6m	-65.45%
Volume	83,115
Z Score	-29.01

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EBR/OXUR pay a dividend?

Capital-return profile for this ticker.

Performance

EBR/OXUR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EBR/OXUR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.9%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

EBR/OXUR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.0

Neutral momentum band

Price vs 200-day MA

-69.4%

50/200-day relationship not available

Beta (5Y)

-0.15

Less volatile than the market

Sharpe ratio

-1.74

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EBR/OXUR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ebr/OXUR stock rating?

ebr/OXUR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ebr/OXUR analysis?

The full report lives at /stocks/ebr/OXUR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ebr/OXUR?

The latest report frames ebr/OXUR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ebr/OXUR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.